Amgen To Present At The 31st Annual J.P. Morgan Global Healthcare Conference

 Amgen To Present At The 31st Annual J.P. Morgan Global Healthcare Conference

PR Newswire

THOUSAND OAKS, Calif., Jan. 3, 2013

THOUSAND OAKS, Calif., Jan. 3, 2013 /PRNewswire/ --Amgen (NASDAQ:AMGN) will
present at the 31^st Annual J.P. Morgan Global Healthcare Conference at 9:00
a.m. Pacific Standard Time on Tuesday, Jan. 8, 2013, at the Westin St. Francis
in San Francisco. Robert A. Bradway, chairman and chief executive officer at
Amgen, will present at the conference. Live audio of the presentation can be
accessed from the Events Calendar on Amgen's website, www.amgen.com, under
Investors. A replay of the webcast will also be available on Amgen's website
for 90 days following the event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe, effective
medicines from lab to manufacturing plant to patient. Amgen therapeutics have
changed the practice of medicine, helping millions of people around the world
in the fight against cancer, kidney disease, rheumatoid arthritis, bone
disease and other serious illnesses. With a deep and broad pipeline of
potential new medicines, Amgen remains committed to advancing science to
dramatically improve people's lives. To learn more about our pioneering
science and vital medicines, visit www.amgen.com. Follow us on
www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)





SOURCE Amgen

Website: http://www.amgen.com